Skip to main content
Clinical Trials/IRCT20190305042935N2
IRCT20190305042935N2
Completed
Phase 3

Evaluation of the therapeutic effect of alkaline water in patients with gastroesophageal reflux disease

Shahre-kord University of Medical Sciences0 sites72 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Gastroesophageal reflux disease.
Sponsor
Shahre-kord University of Medical Sciences
Enrollment
72
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Shahre-kord University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Symptoms of gastroesophageal reflux disease at least 2 times a week for at least 3 months
  • Age between 18 to 40 years

Exclusion Criteria

  • Any pathological problem associated with gastroesophageal reflux disease including Barrett's esophagus and malignancy
  • Having warning signs such as painful and difficulty swallowing, nausea, vomiting and fever

Outcomes

Primary Outcomes

Not specified

Similar Trials